Speaker: Mirwais Wardak, PhD (he/him/his) – Genentech, Inc.
### he/him/hisSpeaker: Nitin Mehrotra, Phd – Alnylam Pharmaceuticals
###Speaker: Suein Choi, MD., PhD. (she/her/hers) – Catholic university of Korea
### she/her/hersSpeaker: Omid Bazgir, PhD (he/him/his) – Genentech Inc.
### he/him/hisChair and Speaker: Dongyang Liu, PhD (he/him/his) – Drug Clinical Trial Center, Peking University Third Hospital
### he/him/his @@@ Aleksandra Galetin, PhD (she/her/hers) – University of Manchester ### 2379986###Chair and Speaker###Professor of Translational Pharmacokinetics ###University of Manchester###Chair and Speaker: Aleksandra Galetin, PhD (she/her/hers) – University of Manchester
### she/her/hers @@@ Michael Gertz, PhD (he/him/his) – F. Hoffmann-La Roche ### 2413383###Speaker###Expert Scientist###F. Hoffmann-La Roche###Speaker: Michael Gertz, PhD (he/him/his) – F. Hoffmann-La Roche
### he/him/his @@@ Lixia Zhang, PhD – FDA ### 2413382###Speaker###Staff Fellow###FDA###Speaker: Lixia Zhang, PhD – FDA
###Facilitator: Peter Bonate, PhD – Executive Director at Astellas/ Editor-in-Chief, JPKPD
###Chair and Speaker: Mirwais Wardak, PhD (he/him/his) – Genentech, Inc.
### he/him/his @@@ Owen Richfield, PhD – Yale University ### 2360744###Co-Chair###Postdoctoral Fellow###Yale University###Co-Chair: Owen Richfield, PhD – Yale University
### @@@ Marc D. Normandin, PhD (he/him/his) – Yale University ### 2360745###Speaker###Director of Yale PET Core, Associate Professor of Radiology & Biomedical Imaging###Yale University###Speaker: Marc D. Normandin, PhD (he/him/his) – Yale University
### he/him/his @@@ Guobao Wang, PhD (he/him/his) – University of California, Davis ### 2360746###Speaker###Professor of Radiology###University of California, Davis###Speaker: Guobao Wang, PhD (he/him/his) – University of California, Davis
### he/him/hisSpeaker: Yanguang Cao, PhD (he/him/his) – University of North Carolina at Chapel Hill
### he/him/hisSpeaker: Neelima Thanneer, MS – BMS
###Chair: Nieves Velez de Mendizabal, PhD (she/her/hers) – Eli Lilly and Company
### she/her/hers @@@ Stacey Tannenbaum, PhD, FISoP (she/her/hers) – Metrum Research Group ### 2360692###Chair###VP of Scientific Engagement###Metrum Research Group###Chair: Stacey Tannenbaum, PhD, FISoP (she/her/hers) – Metrum Research Group
### she/her/hers @@@ Ana Ruiz, PharmD, PhD – Gilead Sciences ### 2360693###Panelist###Executive Director, Head of the Pharmacometrics Group###Gilead Sciences###Panelist: Ana Ruiz, PharmD, PhD – Gilead Sciences
### @@@ Julia Korell, PhD (she/her/hers) – Metrum Research Group ### 2360694###Panelist###Principal Scientist II###Metrum Research Group###Panelist: Julia Korell, PhD (she/her/hers) – Metrum Research Group
### she/her/hers @@@ Gemma Dickinson, PhD (she/her/hers) – Eli Lilly and Company ### 2360695###Panelist###Vice President and Head of Global PK/PD and Pharmacometrics###Eli Lilly and Company###Panelist: Gemma Dickinson, PhD (she/her/hers) – Eli Lilly and Company
### she/her/hers @@@ Joga Gobburu, PhD MBA (he/him/his) – University of Maryland ### 2380204###Panelist###Professor###University of Maryland###Panelist: Joga Gobburu, PhD MBA (he/him/his) – University of Maryland
### he/him/his